Navigation Links
World Radiopharmaceuticals Market to Reach USD 5.5bn in 2017, According to M&M Report Available at MarketPublishers.com
Date:8/19/2013

London, UK (PRWEB) August 19, 2013

Globally, the radiopharmaceuticals market is poised to reach USD 5.5 billion by end-2017, at a CAGR of about 8% during 2012-2017. Tc-99m diagnostic procedures are expected to increase to 20% in mature markets in the long run. Further, upcoming radioisotopes such as radium-223 chloride (alpharadin) and gallium-68 have big potential for clinical applications.

The therapy market is primarily driven by its oncologic applications, where radioisotopes are being preferred due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the upcoming future. The isotope has huge potential to grab market share from existing beta emitters and brachytherapy. North America is the dominant market for diagnostic radioisotopes with about 50% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Cardinal Health, Inc., GE Healthcare, Covidien, Plc, Lantheus Medical Imaging, Inc., Nordion, Inc., IBA Group, and Siemens Healthcare are the leading players in the radiopharmaceuticals market worldwide. The stable isotopes market is led by Cambridge Isotope Laboratories (CIL) and Isotec (Sigma Aldrich).

Comprehensive research study “Nuclear Medicine/Radiopharmaceuticals (SPECT/PET Radioisotopes (Technetium, F-18)), (Beta/Alpha radiation therapy (I131, Y-90)), (Applications (Cancer/Oncology, Cardiac)) & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017” elaborated by MarketsandMarkets (M&M) has been recently published by Market Publishers Ltd.

Report Details:

Title: Nuclear Medicine/Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017
Published: April, 2013
Pages: 346
Price: US$ 4,650.00
http://marketpublishers.com/report/life_sciences/healthcare/nuclear-medicineradiopharmaceuticals-spectpet-radioisotopes-technetium-f-18-betaalpha-radiation-therapy-i131-y-90-applications-canceroncology.html

The report provides an in-depth assessment of the global radioisotope and stable isotope markets, categorised on the basis of the type of isotope, applications and geography. Breaking down both markets into segments and sub-segments, the report presents an exhaustive value analysis for the years 2010, 2011, 2012, with extensive forecasts to 2017. To contribute to a better understanding of the sector, the study gives granular insights into major market drivers & restraints, threats and opportunities, winning imperatives & burning industry issues. Furthermore, the competitive landscape overview along with the profiles of top players including their financials, products and services, strategies, developments, and other company-specific information can also be found in the research report.

Report Features:

  •     In-depth analysis of the global radioisotope and stable isotope markets and its segments and sub-segments.
  •     Historical and current data on the industry performance.
  •     Overview of the market dynamics, including drivers, restrains, threats and opportunities.
  •     Discussion of the burning industry issues and winning imperatives.
  •     In-depth review of the regulative affairs.
  •     Porter’s five forces analysis.
  •     Value chain analysis.
  •     Market share analysis.
  •     Strategic benchmarking and peer evaluation.
  •     Information on the prevailing trends and developments in the market.
  •     Analysis of key market segments and sub-segments, with an exhaustive value analysis.
  •     Geographical market analysis.
  •     Insights into the competitive scenario.
  •     Profiles of the leading players (including details on financials, product and services, strategies undertaken, and recent developments).
  •     Market future forecast to 2017.

More topical research studies by MarketsandMarkets can be found at http://marketpublishers.com/members/marketsnmarkets/info.html/.

About Us:

MarketPublishers.com is a multilingual hypermarket offering hundreds of thousands of comprehensive studies of motley markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality market intelligence as well as support critical decision-making.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11039508.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
2. Measles Deaths Falling Worldwide
3. Surprising results for use of dialysis for kidney failure in developing world
4. Blond Genes May Vary Around the World
5. Infection Causes 1 in 6 Cancers Worldwide: Study
6. New initiative aims to increase mobility for disabled children worldwide
7. World Health Assembly endorses new plan to increase global access to vaccines
8. People Who Lived Near World Trade Center Report More Lung Disease
9. After 25 years, World No Tobacco Day is making an impact
10. Brave New World of Genetics Requires Safeguards, Experts Say
11. UICC World Cancer Congress -- Aug. 27-30, 2012 -- Montreal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: